• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

    1/16/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care
    Get the next $STSS alert in real time by email

    NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the "Strategic Advisor"), pursuant to which SOL Markets has agreed to restrict sales of its advisory warrants and any underlying shares. The lock-up reflects strong conviction in STSS's execution roadmap and reinforces alignment between the parties. This comes after the company's recent announcement that its Board of Directors approved a share buyback program for up to $100 million.

    Under the terms of the agreement, the Strategic Advisor has voluntarily agreed not to sell, transfer, assign, pledge, hedge, or otherwise dispose of any warrants or underlying shares of STSS common stock for a period of 90 days from the date of signing this agreement. The lock-up arrangement applies to all warrants and underlying shares held by SOL Markets that were issued in connection with advisory and strategic support services and is effective as of January 16, 2026. This commitment reinforces the Strategic Advisor's alignment with the objectives of STSS and demonstrates confidence in the strategic roadmap and anticipated growth of the combined initiatives.

    "When a long-term partner voluntarily commits to a lock-up, it sends a powerful signal of alignment, conviction, and confidence in the Company's future," said Paul Danner, Executive Chairman of STSS. "We are pleased to have secured this commitment and believe it reflects the strength of our strategy and the opportunities ahead for Sharps."

    James Zhang, Strategic Advisor to STSS added, "We are proud to deepen our alignment with STSS through this lock-up agreement. We have not sold any shares or warrants thus far, and formalizing this commitment further reflects our confidence in Sharps' strategy, execution discipline, and near-term catalysts. We believe Sharps is building toward a differentiated market position, and we are fully committed to supporting the Company's next phase of growth."

    Through strategic partnerships, including with Coinbase, Crypto.com and Jupiter, in addition to its Solana treasury and upcoming product research and development initiatives, STSS is driving the development of a universal framework for digital identity and authentication.

    STSS's management team has been and continues to conduct institutional investor-focused non-deal roadshows to actively engage with the investment community and showcase the company's upcoming initiatives.



    Forward Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this release other than statements of historical fact are forward-looking statements, including statements regarding the Company's execution of its Solana digital asset treasury strategy, the anticipated benefits of its collaboration with Sol Markets, Coinbase, Crypto.com and Jupiter, and the potential opportunities such initiatives may create for retail and institutional audiences. Forward-looking statements are based on current expectations, assumptions, and beliefs, and involve risks and uncertainties that could cause actual results to differ materially.

    These risks and uncertainties include, among others: the Company's ability to successfully execute its Solana treasury strategy; volatility in the market price of SOL and other digital assets; changes in the regulatory or legal environment; competitive pressures; and general market, economic, and business conditions. Additional risks are described in the "Risk Factors" section of the Company's filings with the Securities and Exchange Commission (the "SEC"), which are available on the SEC's website at www.sec.gov.

    Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise these statements, whether as a result of new information, future developments, or otherwise, except as required by law.

    About Sharps Technology

    Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features.

    The Company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

    Contact

    [email protected]



    Primary Logo

    Get the next $STSS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STSS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Saba Capital Management, L.P. sold $240,010 worth of shares (107,465 units at $2.23) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    1/15/26 12:48:07 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    New insider Saba Capital Management, L.P. claimed ownership of 1,656,635 shares (SEC Form 3)

    3 - Sharps Technology Inc. (0001737995) (Issuer)

    1/15/26 12:33:16 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Investment Officer Zhang Yuwen

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    10/6/25 4:32:03 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

    NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the "Strategic Advisor"), pursuant to which SOL Markets has agreed to restrict sales of its advisory warrants and any underlying shares. The lock-up reflects strong conviction in STSS's execution roadmap and reinforces alignment between the parties. This comes after the company's recent announcement that its Board of Directors approved a share buyback program for up to $100 million. Under the terms of the agreement, the Strategic Advisor has voluntarily agreed not to sell, transfer, assign, pledge, hedge, or otherwise dispo

    1/16/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana Validator

    NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company implementing a Solana-based digital asset treasury strategy, today announced the expansion of its relationship with Coinbase Institutional, a leading provider of custody, prime brokerage, derivatives, staking, and trading services, through the launch of a jointly supported institutional-grade validator on the Solana network. The STSS Validator, operated by Coinbase and built on Coinbase Institutional's market-proven infrastructure stack, represents a meaningful shift for the company as it moves from a Solana treasury participant to a direct contributor to t

    1/12/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy

    NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company"), a U.S.-based medical device sales and distribution platform that has adopted a Solana-based treasury strategy, today announced financial results for the third quarter ended September 30, 2025, and provided updates on the execution of its capital markets and digital asset initiatives. "The third quarter was transformative for Sharps Technology," said Paul K. Danner, Executive Chairman. "Our adoption of a Solana-based treasury strategy, combined with a successful $411 million PIPE financing, has created the strongest balance sheet in the Company's history. With more than two million SOL in our tre

    11/17/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Sharps Technology Inc.

    SCHEDULE 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    1/15/26 3:30:22 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Sharps Technology Inc.

    SCHEDULE 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    1/15/26 3:05:16 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Sharps Technology Inc.

    SCHEDULE 13G - Sharps Technology Inc. (0001737995) (Subject)

    1/15/26 2:58:26 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ruemler Timothy James increased direct ownership by 294% to 40,218 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:45:47 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Crescenzo Andrew R. bought $256,400 worth of Option (40,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:34 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Monroe Jason L. bought $512,800 worth of Option (80,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:36 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Financials

    Live finance-specific insights

    View All

    Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

    NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Funded from the Company's recent PIPE equity raise, Sharps Technology now holds over 2 million SOL, creating a SOL treasury currently valued north of $400M. Sharps Technology intends to provide regular updates on its SOL holdings and performan

    9/2/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (NASDAQ:SNGX) and Sharps Technology Inc. (NASDAQ:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Soligenix: https://www.redchip.com/assets/access/sngx_accessSharps Technology: https://www.redchip.com/assets/access/stss_accessIn an exclusive interview, Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix, appears on the RedChip Small Stocks Big Money™ show on B

    6/7/24 9:00:00 AM ET
    $SNGX
    $STSS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American Resources Corp. (NASDAQ:AREC) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Sharps Technology: https://www.redchip.com/assets/access/stss_accessReviva Pharmaceuticals: https://www.redchip.com/assets/access/rvph_accessAmerican Resources Corp: https://www.redchip.com/assets/access/arec_accessAbout The RedChip

    9/29/23 9:00:00 AM ET
    $AREC
    $RVPH
    $STSS
    Coal Mining
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STSS
    Leadership Updates

    Live Leadership Updates

    View All

    Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

    NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ:STSS) (NASDAQ:STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is working to create new sales and distribution opportunities through the addition of new North American 3PL partnerships to expand its reach into the global healthcare market. These additional third-party logistics partnerships, along with a developing alliance with Roncadelle Operations, a driving force in the development of safe, novel medical drug delivery devices, would combine the strengths and capabilities of the two companies to develop, market and distribute unique dru

    2/16/24 2:42:54 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales

    Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the market Product qualification and sales initiatives underway as company prepares for U.S. commercial operations NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, is pleased to announce the appointment of Ben Scheu as Senior Director of Sales to lead commercial operations as the Company prepares to launch products to the market.

    7/12/23 8:33:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Justin Page as Vice President of Technical Operations

    NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company", "Sharps") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as Vice President of Technical Operations. In his role, Mr. Page will be responsible for managing all aspects of Sharps' engineering operations. His primary focus will be to provide the leadership and technical expertise to support the prefillable syringe collaboration with Nephron Pharmaceuticals at the InjectEZ facility. These efforts will include the support for the injection molding of the specialty components and the high speed assembl

    2/9/23 9:21:23 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    11/13/24 4:50:17 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    10/9/24 9:01:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Sharps Technology Inc.

    SC 13G - Sharps Technology Inc. (0001737995) (Subject)

    2/14/24 11:14:11 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care